Elk River Wealth Management LLC Grows Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Elk River Wealth Management LLC raised its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 0.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 66,181 shares of the company’s stock after purchasing an additional 217 shares during the quarter. Elk River Wealth Management LLC owned 0.08% of HealthEquity worth $5,417,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in HQY. Vanguard Group Inc. lifted its stake in shares of HealthEquity by 1.7% during the 1st quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company’s stock valued at $715,783,000 after buying an additional 149,133 shares in the last quarter. Wasatch Advisors LP raised its holdings in HealthEquity by 8.3% during the first quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock valued at $604,803,000 after acquiring an additional 569,249 shares during the period. Motley Fool Asset Management LLC lifted its position in shares of HealthEquity by 3,001.0% in the first quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock valued at $307,097,000 after acquiring an additional 3,640,748 shares in the last quarter. Clearbridge Investments LLC boosted its stake in shares of HealthEquity by 1.9% in the second quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock worth $204,915,000 after acquiring an additional 43,491 shares during the period. Finally, Mackenzie Financial Corp grew its position in shares of HealthEquity by 16.0% during the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock worth $203,822,000 after purchasing an additional 325,906 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Insider Activity

In other news, Vice Chairman Stephen Neeleman sold 35,000 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the transaction, the insider now owns 89,769 shares of the company’s stock, valued at approximately $7,168,952.34. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Frank Corvino sold 1,247 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the transaction, the director now owns 4,823 shares of the company’s stock, valued at $387,093.98. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total value of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares in the company, valued at $7,168,952.34. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 44,497 shares of company stock valued at $3,579,769. Corporate insiders own 2.20% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on HQY shares. Barrington Research reissued an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a report on Friday, September 20th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. JMP Securities reissued a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. Bank of America decreased their price target on shares of HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, September 4th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat.com, HealthEquity currently has an average rating of “Buy” and a consensus price target of $103.83.

HealthEquity Trading Down 0.9 %

HealthEquity stock traded down $0.74 during midday trading on Monday, reaching $84.68. The stock had a trading volume of 18,907 shares, compared to its average volume of 616,506. The company has a quick ratio of 4.10, a current ratio of 4.10 and a debt-to-equity ratio of 0.51. The company has a fifty day moving average of $77.14 and a 200 day moving average of $79.28. HealthEquity, Inc. has a 52-week low of $61.81 and a 52-week high of $88.26. The firm has a market cap of $7.37 billion, a price-to-earnings ratio of 92.85, a price-to-earnings-growth ratio of 1.31 and a beta of 0.52.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The company had revenue of $299.93 million for the quarter, compared to the consensus estimate of $284.48 million. On average, analysts anticipate that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.